• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大脑葡萄糖代谢受损和认知功能减退预示着轻度认知障碍的恶化。

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment.

作者信息

Arnáiz E, Jelic V, Almkvist O, Wahlund L O, Winblad B, Valind S, Nordberg A

机构信息

Karolinska Institutet, Department of Clinical Neuroscience, Occupational Therapy, and Elderly Care Research (NEUROTEC), Huddinge University Hospital, Sweden.

出版信息

Neuroreport. 2001 Mar 26;12(4):851-5. doi: 10.1097/00001756-200103260-00045.

DOI:10.1097/00001756-200103260-00045
PMID:11277595
Abstract

The objective of this study was to assess whether reduced glucose metabolism (rCMRGlu) and cognitive functioning could predict development of Alzheimer's disease (AD) in subjects with mild cognitive impairment (MCI). Twenty MCI patients underwent baseline and follow-up investigations of rCMRGlu, as measured by PET, and cognitive function measured by neuropsychological test assessments. Subjects were clinically followed up with an average interval of 36.5 months. Two groups were obtained after the second clinical assessment. Nine patients were diagnosed as AD and classified as progressive MCI (P-MCI), whereas 11 patients remained clinically stable and were classified as stable MCI (S-MCI). There were no differences in demographic variables or baseline MMSE between the two subgroups. Logistic regression indicated the two variables that most effectively predicted future development of AD were rCMRGlu from the left temporoparietal area and performance on the block design. These combined measures gave an optimal 90% correct classification rate, whereas only rCMRGlu or neuropsychology alone gave 75% and 65% correct classification, respectively. Measures of temporoparietal cerebral metabolism and visuospatial function may aid in predicting the evolution to AD for patients with MCI.

摘要

本研究的目的是评估葡萄糖代谢降低(rCMRGlu)和认知功能是否能够预测轻度认知障碍(MCI)患者患阿尔茨海默病(AD)的情况。20名MCI患者接受了rCMRGlu的基线和随访检查(通过PET测量)以及认知功能检查(通过神经心理学测试评估)。对受试者进行临床随访,平均间隔时间为36.5个月。第二次临床评估后分为两组。9名患者被诊断为AD,并归类为进展性MCI(P-MCI),而11名患者临床症状保持稳定,被归类为稳定MCI(S-MCI)。两个亚组在人口统计学变量或基线简易精神状态检查表(MMSE)方面没有差异。逻辑回归表明,最能有效预测AD未来发展的两个变量是左颞顶叶区域的rCMRGlu和积木设计测试的表现。这些综合指标的正确分类率最佳,为90%,而仅rCMRGlu或仅神经心理学测试的正确分类率分别为75%和65%。颞顶叶脑代谢和视觉空间功能的测量可能有助于预测MCI患者向AD的演变。

相似文献

1
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment.大脑葡萄糖代谢受损和认知功能减退预示着轻度认知障碍的恶化。
Neuroreport. 2001 Mar 26;12(4):851-5. doi: 10.1097/00001756-200103260-00045.
2
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.轻度认知障碍转化为阿尔茨海默病时伴随的脑代谢变化:一项PET随访研究
Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. doi: 10.1007/s00259-003-1194-1. Epub 2003 May 23.
3
[The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].[阿尔茨海默病伴轻度认知障碍患者局部脑葡萄糖代谢率的比较]
Zhonghua Yi Xue Za Zhi. 2002 Dec 10;82(23):1613-6.
4
Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment.老年抑郁症和轻度认知障碍患者存在脑淀粉样血管病时的区域性葡萄糖代谢。
J Affect Disord. 2018 Oct 15;239:30-36. doi: 10.1016/j.jad.2018.06.029. Epub 2018 Jun 18.
5
Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.阿尔茨海默病患者的认知功能障碍评估的 CERAD 对半脑大脑 FDG PET 的相关性。
Clin EEG Neurosci. 2011 Apr;42(2):71-6. doi: 10.1177/155005941104200207.
6
Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism.阿尔茨海默病中的认知障碍与脑室宽度和经萎缩校正的皮质葡萄糖代谢相关。
Neuroradiology. 1995 May;37(4):270-7. doi: 10.1007/BF00588331.
7
A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.一项针对认知健康的老年人、轻度认知障碍和早期阿尔茨海默病患者大脑葡萄糖和酮体代谢的横断面比较。
Exp Gerontol. 2018 Jul 1;107:18-26. doi: 10.1016/j.exger.2017.07.004. Epub 2017 Jul 12.
8
Hippocampal formation glucose metabolism and volume losses in MCI and AD.轻度认知障碍和阿尔茨海默病中海马结构的葡萄糖代谢及体积损失
Neurobiol Aging. 2001 Jul-Aug;22(4):529-39. doi: 10.1016/s0197-4580(01)00230-5.
9
Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.认知障碍是从轻度认知障碍向阿尔茨海默病转化的独立预测因子,与脑代谢降低有关。
J Clin Psychiatry. 2017 Nov/Dec;78(9):e1187-e1196. doi: 10.4088/JCP.16m11367.
10
Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.轻度认知障碍、阿尔茨海默病与正常衰老之间的病理学及烟碱受体结合差异
Arch Neurol. 2006 Dec;63(12):1771-6. doi: 10.1001/archneur.63.12.1771.

引用本文的文献

1
Research progress in predicting the conversion from mild cognitive impairment to Alzheimer's disease via multimodal MRI and artificial intelligence.通过多模态磁共振成像和人工智能预测轻度认知障碍向阿尔茨海默病转化的研究进展
Front Neurol. 2025 Jun 2;16:1596632. doi: 10.3389/fneur.2025.1596632. eCollection 2025.
2
The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.使用基于个体的 FDG-PET 感兴趣区容积预测从轻度认知障碍到痴呆的转化。
BMC Med Imaging. 2024 Mar 28;24(1):75. doi: 10.1186/s12880-024-01256-x.
3
Alterations in cognitive function and blood biomarkers following transcranial direct current stimulation in patients with amyloid positron emission tomography-positive Alzheimer's disease: a preliminary study.
淀粉样蛋白正电子发射断层扫描阳性阿尔茨海默病患者经颅直流电刺激后认知功能和血液生物标志物的变化:一项初步研究。
Front Neurosci. 2023 Dec 21;17:1327886. doi: 10.3389/fnins.2023.1327886. eCollection 2023.
4
Hypometabolism, Alzheimer's Disease, and Possible Therapeutic Targets: An Overview.代谢低下、阿尔茨海默病与可能的治疗靶点:概述。
Cells. 2023 Aug 8;12(16):2019. doi: 10.3390/cells12162019.
5
Comprehensive review of task-based neuroimaging studies of cognitive deficits in Alzheimer's disease using electrophysiological methods.使用电生理方法对阿尔茨海默病认知缺陷的基于任务的神经影像学研究进行综合回顾。
Ageing Res Rev. 2023 Jul;88:101950. doi: 10.1016/j.arr.2023.101950. Epub 2023 May 6.
6
Cellular Stress Response (Hormesis) in Response to Bioactive Nutraceuticals with Relevance to Alzheimer Disease.细胞应激反应(抗逆)对具有阿尔茨海默病相关性的生物活性营养保健品的反应。
Antioxid Redox Signal. 2023 Mar;38(7-9):643-669. doi: 10.1089/ars.2022.0214.
7
A multi-hit hypothesis for an APOE4-dependent pathophysiological state.载脂蛋白 E4 依赖性病理生理状态的多打击假说。
Eur J Neurosci. 2022 Nov;56(9):5476-5515. doi: 10.1111/ejn.15685. Epub 2022 Jun 6.
8
Comparing model-based cerebrovascular physiomarkers with DTI biomarkers in MCI patients.比较基于模型的脑血管生理标志物与 MCI 患者的 DTI 生物标志物。
Brain Behav. 2019 Aug;9(8):e01356. doi: 10.1002/brb3.1356. Epub 2019 Jul 9.
9
Regional protein expression in human Alzheimer's brain correlates with disease severity.人脑阿尔茨海默病中区域蛋白的表达与疾病严重程度相关。
Commun Biol. 2019 Feb 4;2:43. doi: 10.1038/s42003-018-0254-9. eCollection 2019.
10
Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment.轻度认知障碍老年患者的认知特征及MRI萎缩评级
Front Aging Neurosci. 2018 Nov 21;10:384. doi: 10.3389/fnagi.2018.00384. eCollection 2018.